China Nuokang Bio-Pharmaceutical Inc.

No structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).

• 15-12BFORM 15-12BFeb 20, 2013
• S-8 POSPOST-EFFECTIVE AMENDMENT NO.1 TO FORM S-8Feb 20, 2013
• SC 13G/AFeb 13, 2013
• SC 13E3/ASCHEDULE 13E-3 AMENDMENT NO. 7Feb 7, 2013
• 6-KFORM 6-KFeb 7, 2013
• 25-NSEFeb 6, 2013
• SC 13E3/ASCHEDULE 13E-3 AMENDMENT NO.6Jan 29, 2013
• 6-KFORM 6-KJan 29, 2013
• SC 13E3/ASCHEDULE 13E-3 AMENDMENT NO. 5Jan 18, 2013
• SC 13E3/ASCHEDULE 13E-3 AMENDMENT NO. 4Jan 15, 2013
• 6-KFORM 6-KJan 15, 2013
• SC 13E3/ASCHEDULE 13E-3 AMENDMENT NO. 3Dec 17, 2012
• 6-KFORM 6-KDec 17, 2012
• 6-KFORM 6-KNov 27, 2012
• SC 13E3/ASCHEDULE 13E-3 AMENDMENT NO. 2Nov 27, 2012

Event-driven situations (1)

• Feb 7, 2013Going privatecompleted